Incorporation of L-azetidine-2-carboxylic acid into hemoglobin S in sickle erythrocytes in vitro
- PMID: 974136
- DOI: 10.1016/0005-2787(76)90080-0
Incorporation of L-azetidine-2-carboxylic acid into hemoglobin S in sickle erythrocytes in vitro
Abstract
L-Azetidine-2-carboxylic acid, the naturally occurring lower homologue of L-proline, is incorporated into hemoglobin S (sickle hemoglobin) in vitro. Sickle erythrocytes from patients with sickle cell anemia incubated with L-[3H] azetidine-2-carboxylate synthesized radiolabeled hemoglobin which when isolated from cell lysates, co-chromatographed with hemoglobin S on DEAE-cellulose columns. The alpha/beta ratio of azetidine carboxylate incorporation into the globin chains of sickle hemoglobin was 0.94, which is consistent with the presence of four proline residues in each polypeptide chain. Incorporation of azetidine carboxylate into hot trichloroacetic acid-insoluble material in sickle erythrocytes indicated that the homologue was present in the polypeptide backbone of the globin chains of sickle hemoglobin. Amino acid analysis of the hot trichloroacetic acid-insoluble material from sickle erythrocytes which had been incubated with radiolabeled azetidine carboxylate indicated that 75% of the radioactivity could be accounted for as intact homologue while 20% of the radioactivity co-chromatographed with alanine. These results suggest that azetidine carboxylate is incorporated unaltered into hemoglobin S in addition to being metabolized to alanine in sickle erythrocytes prior to incorporation into protein. The kinetics of thermal precipitation of hemoglobin S (oxygen ligand) into which radioactive azetidine carboxylate or radioactive proline had been incorporated in vitro is identical. This observation, together with the behavior of hemoglobin S and the globin chains from hemoglobin S containing azetidine carboxylate during ion-exchange chromatography, indicates that homologue replacement of prolyl residues does not significantly alter the overall charge or stability of the hemoglobin S tetramer. Azetidine carboxylate did not inhibit uptake of radiolabeled proline by sickle erythrocytes suggesting that the homologue does not adversely affect amino acid transport in these cells.
Similar articles
-
Incorporation of L-azetidine-2-carboxylic acid into hemoglobin in rabbit reticulocytes in vitro.J Biol Chem. 1975 Feb 25;250(4):1464-71. J Biol Chem. 1975. PMID: 1112811
-
Effect of L-azetidine 2-carboxylic acid on growth and proline metabolism in Escherichia coli.Biochim Biophys Acta. 1975 Oct 9;404(2):180-7. doi: 10.1016/0304-4165(75)90324-4. Biochim Biophys Acta. 1975. PMID: 1101962
-
Patterns of hemoglobin assembly in reticulocytes of sickle cell trait individuals.J Biol Chem. 1975 Nov 25;250(22):8630-4. J Biol Chem. 1975. PMID: 1184582
-
Pathophysiologically based drug treatment of sickle cell disease.Trends Pharmacol Sci. 2006 Apr;27(4):204-10. doi: 10.1016/j.tips.2006.02.007. Epub 2006 Mar 13. Trends Pharmacol Sci. 2006. PMID: 16530854 Review.
-
Current perspectives on the kinetics of hemoglobin S gelation.Ann N Y Acad Sci. 1989;565:53-62. doi: 10.1111/j.1749-6632.1989.tb24150.x. Ann N Y Acad Sci. 1989. PMID: 2672971 Review. No abstract available.
Cited by
-
The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors.J Proteome Res. 2013 Aug 2;12(8):3697-706. doi: 10.1021/pr400321x. Epub 2013 Jun 27. J Proteome Res. 2013. PMID: 23763277 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources